Antimicrobial utilization research and activities in Botswana, the past, present and the future
View/ Open
Date
2019-09-23Author
Tiroyakgosi, Celda
Matome, Matshediso
Kgatlwane, Joyce
Paramadhas, Bene D Anand
Malone, Brighid
Mpinda-Joseph, Pinkie
Rwegerera, Godfrey Mutashambara
Maika, Keamogetse
Mashalla, Yohana
Godman, Brian
Maselle, Amos
Publisher
Taylor & Francis, www.tandfonline.comType
Published ArticleMetadata
Show full item recordAbstract
A number of activities are ongoing to reduce AMR in Botswana by improving antimicrobial utilization
across all sectors. However, there is a need to share experiences. With the objective of sharing these,
the second one day symposium was held in the University of Botswana in October 2018 involving both
private and public hospitals. In Lenmed Bokamoso hospital, ESKAPE organisms were associated with 50-
90% of clinical infections; however, there was no correlation between healthcare associated infections
(HAIs) and admission swab positivity with ESKAPE or ESBL isolates. Hang times, the time between
a prescription and IV administration, were also discussed. At Nyangabwe Hospital, the prevalence of
HAIs was 13.54%, 48.9% were laboratory confirmed of which 8.5% were blood stream infections (BSIs).
The prevalence of different bacteria causing neonatal BSIs was also investigated. At Princess Marina
Hospital, positive cultures were seen in 22.4% of blood cultures with contaminants comprising the
majority. Several activities are ongoing in Botswana across sectors as a result of the findings and will be
periodically reported to further improve antibiotic utilization.